T

Texas Institute for Kidney and Endocrine Disorders | Lufkin, TX

Research site
(Unclaimed)
Location
10 Medical Center Boulevard, Ste A, Lufkin, Texas, United States of America
Site insights

Top conditions

Kidney Diseases (2 trials)

Diabetes Mellitus (2 trials)

Diabetic Nephropathies (1 trial)

Coronary Disease (1 trial)

Coronary Artery Disease (1 trial)

Top treatments

BI 685509
LY3298176
Canagliflozin
LY900014
Evolocumab
Tirzepatide
Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on to...

Active, not recruiting
Chronic Kidney Disease
Drug: Matching placebo
Drug: Empagliflozin

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems